ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
A Pilot Study to Evaluate Optical Spectroscopy and SIAscopy of Pigmented Skin Lesions

This study is enrolling participants by invitation only.
Information provided by University of California, Irvine

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  A Pilot Study to Evaluate Optical Spectroscopy and SIAscopy of Pigmented Skin Lesions
Official Title  A Pilot Study to Evaluate the Correlation Between Modified Two Layer Diffuse Optical Spectroscopy and SIAscopy With the Clinical and Histological Examinations of Pigmented Skin Lesions Based on Physiological Parameters
Brief Summary

The purpose of this study is to evaluate the physiological correlates of two imaging devices (1)Modified Two Layer Diffuse Optical Spectroscopy (MTL DOS ) and (2)SIAscopy in the evaluation of atypical moles and melanoma.

A typical moles and melanoma will have a different optical profile based on physiological parameters compared to benign nevus.

The first measured is to determine the hardware variability. From this optical data, a "correction" curve will be developed and this will be applied to all subsequent optical measurements.

Detailed Description

The researcher using special imaging devices to obtain information about a typical mole and melanoma and use this information to determine the different between malignant and benign melanized lesions.

Specifically,to compare malignant vs. benign lesions.

The skin lesion will be exam and diagnose by the physician. The picture will be obtain by the technician use these two devices before and after the treatment of the lesion.

Study Phase
Study Type  Observational
Study Design  Case Control, Prospective
Primary Outcome Measure  establish the variance of optical measurements in human pigmented lesions (benign and malignant). [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
Secondary Outcome Measure 
Condition  Skin Cancer
Intervention 
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Enrolling by invitation
Enrollment  120
Start Date  February 2008
Completion Date February 2010
Eligibility Criteria 

Inclusion Criteria:

  • 18 years or older.
  • Have atypical mole/s and melanoma

Exclusion Criteria:

  • Age less than 18 years old.
  • have NO atypical mole/s and melanoma
Gender Both
Ages 18 Years and older
Accepts Healthy Volunteers Yes
Contacts ††
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00633516
Organization ID P41-RR01192
Secondary IDs ††
Study Sponsor  University of California, Irvine
Collaborators ††
Investigators 
Principal Investigator:     David JB Hsiang, MD     Beckman Laser Institute Medical Clinic    
Information Provided By University of California, Irvine
Verification Date March 2008
First Received Date  March 4, 2008
Last Updated Date March 4, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers